Navigation Links
Alseres Pharmaceuticals, Inc. Complies With NASDAQ Rule Regarding Recently Filed 10-K
Date:3/31/2008

HOPKINTON, Mass., March 31 /PRNewswire-FirstCall/ -- Alseres Pharmaceuticals, Inc. (Nasdaq: ALSE) today announced that the report of the Company's independent registered public accounting firm regarding the Company's 2007 financial statements contained an explanatory paragraph regarding the Company's ability to continue as a going concern. NASDAQ Marketplace Rules require NASDAQ-traded companies to publicly announce if their Annual Report on Form 10-K includes an audit report containing a going concern explanatory paragraph. For further information, please refer to the Company's Annual Report on Form 10-K filed on March 31, 2008.

(Logo: http://www.newscom.com/cgi-bin/prnh/20070608/NEF043LOGO )

About Alseres Pharmaceuticals, Inc.

Alseres Pharmaceuticals, Inc. (ALSE) is engaged in the development of therapeutic and diagnostic products primarily for disorders in the central nervous system (CNS). The Company maintains a world-class intellectual property position in the field of regenerative therapeutics. The Company's energy and focus is reflected in several important initiatives. CETHRIN(R), a recombinant-protein-based drug designed to promote nerve repair after acute spinal cord injury, demonstrated positive interim results in a Phase I/IIa clinical trial. The Company's research and pre-clinical programs include, Inosine for the treatment of spinal cord injury and stroke, Oncomodulin for the treatment of ocular injury and disease and research programs directed at a number of regenerative therapies including bone repair. The Company has a robust molecular imaging development program targeting diagnosis of Parkinson's disease and potential
'/>"/>

SOURCE Alseres Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine news :

1. Alseres Pharmaceuticals, Inc. Raises $5 Million
2. Alseres Pharmaceuticals, Inc. to Present at New York Society of Security Analysts Conference
3. Barr Pharmaceuticals, Inc. Executive Bios
4. Jazz Pharmaceuticals, Inc. Announces LUVOX CR Launch Plans and Reports Development Pipeline Progress at Investor Day Presentation
5. Affinium Pharmaceuticals, Ltd. Announces Initiation of a Phase I Clinical Trial for AFN-1252, its Novel Anti-staphylococcal Antibiotic
6. Acura Pharmaceuticals, Inc. Announces Andrew Reddick, President & CEO, To Take Medical Leave and Appointment of Richard Markham as Chairman of the Board
7. Renhuang Pharmaceuticals, Inc. Retains CCG Elite
8. Lotus Pharmaceuticals, Inc. Implements Environmentally-friendly Cost Saving Strategies
9. Jazz Pharmaceuticals, Inc. to Announce Fourth Quarter and Full Year 2007 Financial Results on February 13, 2008
10. NuView Radiopharmaceuticals, Inc. Secures Exclusive Rights From Thomas Jefferson University for a Tumor-Specific Imaging Agent for the Diagnosis of Breast and Prostate Cancers
11. Jazz Pharmaceuticals, Inc. Announces Submission of Complete Response to FDA Approvable Letter for LUVOX(R) CR
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/23/2008)...TSX: COM, VANCOUVER, July 23 /PRNewswire-FirstCal... today announced that it has entered into an,agree...ment fund managed by,CR Intrinsic Investors, LLC, ...rchase Series A convertible preferred shares for g...nancing will be used for general corporate,purpose...
(Date:7/23/2008)...ce the idea of using DNA to create faster, smaller...scientists have been scrambling to develop success... new research from a professor at Rensselaer Polyt... out artificial computations, all we have to do is... Cognitive Science Mark Changizi has begun to deve...
(Date:7/23/2008)..., July 23 /PRNewswire-USNewswire/ -- The Children,...e a generous $15 million,gift that will enable the...own, Pennsylvania. This gift, made possible by Ath...is one of the largest in the history of,Children,s...milies in the,nearby communities convenient access...
(Date:7/23/2008)...ly 23 /PRNewswire/ -- Times may be tough, but,Holl...there,s nothing like,a dazzling new smile to boost...DDS helps his celebrity clients beam in on success...ngs with it the self-confidence they,need for star...ting a new,high-wattage smile designed by Dr. Kosd...
Breaking Medicine News(10 mins):Health News:Cardiome Announces Preferred Share Financing 2Health News:Cardiome Announces Preferred Share Financing 3Health News:Study suggests human visual system could make powerful computer 2Health News:Study suggests human visual system could make powerful computer 3Health News:$15 Million Donation From The Karabots Foundation Enables The Children's Hospital of Philadelphia to Open a New Pediatric Care Facility in Norristown, Pennsylvania 2Health News:$15 Million Donation From The Karabots Foundation Enables The Children's Hospital of Philadelphia to Open a New Pediatric Care Facility in Norristown, Pennsylvania 3Health News:Rock The Cradle's Bad Boy Landon Brown Owes His Irresistible New Smile to Dr. Michael Kosdon 2
...ng patients on urinary catheters longer than neces...fections and blood infections, said a new study pu... and Patient Safety. The study says that a simple ...f for the doctors might solve this problem. Resear...
...be caused by Streptococcus suis and the first case...f China. The infected persons were mostly farmers ...who handled the contaminated pork products. Accord... are thought to have come from up to 300 different...
...sity of Michigan Cardiovascular Center had present...bon monoxide that can cure inflammations in patien...r heart attacks. In a recent study the scientists ...of carbon monoxide for several weeks after transpl...
...ogressive, neurodegenerative and ultimately fatal ...vanced stage, Alzheimer's disease sufferers lose t...help in every aspect of their everyday living. Bas...rchers say that a mixture of peptides derived from...
Other Medicine News:Health News:Patients Are Given Catheter Longer Than Necessary 2Health News:Research Shows Carbon Monoxide Prevents Inflammations 2
(Date:7/23/2008)... ASPS Study Finds Some Areas of the Body Have G...IGHTS, Ill., July 23 /PRNewswire-USNewswire/ -- Fa...hrough liposuction was found to be,an excellent so...ations,than other areas of the body, reports a Bra...ructive Surgery(R), the official medical journal o...
(Date:7/23/2008)... SEATTLE, July 23 /- Den... that it expects the Independent Data,Monitoring C...rim analysis,of overall survival relating to the C...e AdenoCarcinoma Treatment, also known as D9902B) ...ENGE is the Company,s investigational,active cellu...
(Date:7/22/2008)... BRISBANE, Australia, July 22 /PRNewswire-First...d late yesterday, the Board of Progen,Pharmaceutic...ed that it,had discontinued the PI-88 phase 3 stud...direction to develop its existing portfolio of com...re additional compounds and,opportunities through ...
(Date:7/22/2008)... MINNEAPOLIS, July 22 /- Nonin Med...ing solutions for more than 20 years, has entered,...echnology to measure,regional oxygen saturation. T... is the continuous monitoring of the regional bloo... Early testing data and outcomes from an ongoing c...
Breaking Medicine Technology:Want a Reason to Love Your Lower Belly Fat? It's Rich in Stem Cells 2Dendreon Expects Interim Data Analysis for Phase 3 PROVENGE IMPACT Trial in October 2Dendreon Expects Interim Data Analysis for Phase 3 PROVENGE IMPACT Trial in October 3Dendreon Expects Interim Data Analysis for Phase 3 PROVENGE IMPACT Trial in October 4Progen Terminates PATHWAY Trial & Confirms Focus on Potential High Value Molecules and M&A 2Progen Terminates PATHWAY Trial & Confirms Focus on Potential High Value Molecules and M&A 3Nonin Medical Inc. Announces Entry Into the Cerebral Oximeter Market 2MEDdevice Acquisition Co LLC and Epsilon Securities LLC Identify Sources of Funding 21481 1MEDdevice Acquisition Co LLC and Epsilon Securities LLC Identify Sources of Funding 21481 2The Glazier Group Removes Tomatoes from Menus Nationwide 21478 1The Glazier Group Removes Tomatoes from Menus Nationwide 21478 2Oncolytics Biotech Inc Announces Start of Enrolment in Phase 1 2 Ovarian Cancer Clinical Trial with REOLYSIN 28R 29 5914 1Oncolytics Biotech Inc Announces Start of Enrolment in Phase 1 2 Ovarian Cancer Clinical Trial with REOLYSIN 28R 29 5914 2Oncolytics Biotech Inc Announces Start of Enrolment in Phase 1 2 Ovarian Cancer Clinical Trial with REOLYSIN 28R 29 5914 3Miltenyi Biotec GmbH Acquires Medic Tools AG 5911 1Miltenyi Biotec GmbH Acquires Medic Tools AG 5911 2
...tudy results show,that elevated lipoprotein-associ...specific inflammatory enzyme associated with,unsta...e, is,especially predictive of heart disease risk ... medical condition that affects nearly,50 million ...rday,at the American College of Cardiology,s annua...
...leveland Clinic,researchers today report that the ...oprotein cholesterol (HDL) or the "good",cholester...of,plaque buildup in the coronary arteries as meas....D., Chairman of Cardiovascular Medicine at,Clevel...trial, will,present the study on Monday, March 26 ...
Other Medicine Technology:Study Presented at the ACC Shows Inflammatory Enzyme Lp-PLA2,Predicts Heart Disease Risk in Metabolic Syndrome Patients 2Study Presented at the ACC Shows Inflammatory Enzyme Lp-PLA2,Predicts Heart Disease Risk in Metabolic Syndrome Patients 3Cholesterol Drug Fails to Slow Progression of Coronary Disease,Cleveland Clinic Study Reports 2Cholesterol Drug Fails to Slow Progression of Coronary Disease,Cleveland Clinic Study Reports 3Cholesterol Drug Fails to Slow Progression of Coronary Disease,Cleveland Clinic Study Reports 4
...tories is a national reference laboratory and a wo...nd development. ARUP offers an extensive test menu...nical and anatomic pathology. Owned by the Univers...re than half of the nation's university teaching h...
...tories is a national reference laboratory and a wo...nd development. ARUP offers an extensive test menu...nical and anatomic pathology. Owned by the Univers...re than half of the nation's university teaching h...
...tories is a national reference laboratory and a wo...nd development. ARUP offers an extensive test menu...nical and anatomic pathology. Owned by the Univers...re than half of the nation's university teaching h...
...tories is a national reference laboratory and a wo...nd development. ARUP offers an extensive test menu...nical and anatomic pathology. Owned by the Univers...re than half of the nation's university teaching h...
Medicine Products: